VivoSeq
Oncology

Brain Tumors

0

Pipeline Programs↗

10

Active Trials↗

3

Companies Involved↗

Brain Tumors is an early-stage landscape with 0 programs across 3 companies. The most active players are Alaunos Therapeutics, BioNumerik Pharmaceuticals, Inc., Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

76/100

Attrition Rate

19/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Alaunos Therapeutics

0 programs

PreclinicalB

BioNumerik Pharmaceuticals, Inc.

0 programs

PreclinicalEli Lilly logo

Eli Lilly

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

64

clinical trials

Completed37 · 58%
Terminated8 · 13%
Recruiting6 · 9%
Unknown status5 · 8%
Withdrawn4 · 6%
Not yet recruiting3 · 5%
Other1 · 2%

Clinical Trials

Trial Activity

64 trials

A Study of Sotorasib in People With Brain Tumors
Recruiting·MMemorial Sloan Kettering Cancer Center·Phase 1·NCT06807619·16 enrolled
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
Recruiting·UUniversity of Texas Southwestern Medical Center·N/A·NCT03067467·25 enrolled
Biological Collection of Brain Tumors
Recruiting·HHospices Civils de Lyon·N/A·NCT05571579·500 enrolled
Feasibility of FMISO in Brain Tumors
Recruiting·OOHSU Knight Cancer Institute·Phase 2·NCT03649880·50 enrolled
Short Versus Long-term Levetiracetam in Brain Tumors
Recruiting·TTata Memorial Centre·Phase 3·NCT06442748·604 enrolled
DLL3 CAR-T Therapy Targeting Brain Tumors
Recruiting·SShenzhen Geno-Immune Medical Institute·Phase 1/2·NCT07180927·30 enrolled
Fimepinostat in Treating Brain Tumors in Children and Young Adults
Active, not recruiting·SSabine Mueller, MD, PhD·Phase 1·NCT03893487·30 enrolled
An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
Not yet recruiting·MMayo Clinic·Phase 2·NCT06667726·47 enrolled
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
Not yet recruiting·UUniversity of Alabama at Birmingham·Phase 1·NCT05676489·28 enrolled
Development and Validation of an Artificial Intelligence Foundation Model for Hierarchical Classification of Central Nervous System Tumors Using Hematoxylin and Eosin Whole-Slide Images
Not yet recruiting·HHuashan Hospital·N/A·NCT07685301·20,000 enrolled
A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors
Completed·National Cancer Institute (NCI)·Phase 1·NCT00001502·30 enrolled
Imaging Brain Tumors With FACBC and Methionine
Completed·MMemorial Sloan Kettering Cancer Center·N/A·NCT00597246·30 enrolled
Lobradimil and Carboplatin in Treating Children With Brain Tumors
Completed·National Cancer Institute (NCI)·Phase 2·NCT00019422
DM-CHOC-PEN Plus Radiation for Brain Tumors
Completed·DDEKK-TEC, Inc.·Phase 1·NCT03371004·19 enrolled
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Completed·SSt. Jude Children's Research Hospital·Phase 1·NCT03434262·68 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)